Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man
- PMID: 444352
- PMCID: PMC1429660
- DOI: 10.1111/j.1365-2125.1979.tb00941.x
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man
Abstract
1 Fluphenazine (1,2-ethanol 14C) was administered to seven human subjects as the dihydrochloride and as the enanthate and decanoate esters. 2 The subjects had previously been treated with fluphenazine injections for at least 6 months. 3 Fluphenazine was separated from its radioactive metabolites by selective solvent extraction. Plasma concentrations were measured for up to 21 days after dosing. 4 The preparations showed differences in peak concentrations, times of the peaks and half-times of the elimination phase. The longest half-times occurred with the decanoate and the shortest with the dihydrochloride. 5 It is postulated that the differences in kinetics relate principally to the release of the compound from the site of injection. 6 There was no evidence for presence of the esters in plasma, urine or faeces.
Similar articles
-
Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.J Pharm Sci. 1976 Sep;65(9):1310-5. doi: 10.1002/jps.2600650912. J Pharm Sci. 1976. PMID: 966144
-
Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs.J Pharm Sci. 1976 Apr;65(4):502-507. doi: 10.1002/jps.2600650407. J Pharm Sci. 1976. PMID: 1271246
-
Methods for study of fluphenazine kinetics in man.J Pharm Pharmacol. 1976 Dec;28(12):869-73. doi: 10.1111/j.2042-7158.1976.tb04082.x. J Pharm Pharmacol. 1976. PMID: 12260
-
Clinical pharmacokinetics of the depot antipsychotics.Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003. Clin Pharmacokinet. 1985. PMID: 2864156 Review.
-
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.J Psychiatry Neurosci. 1994 Jul;19(4):254-64. J Psychiatry Neurosci. 1994. PMID: 7918346 Free PMC article. Review.
Cited by
-
Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients.Psychopharmacology (Berl). 1988;96(2):206-11. doi: 10.1007/BF00177561. Psychopharmacology (Berl). 1988. PMID: 3148147
-
Comparative enzyme-inducing effects of chlorpromazine and fluphenazine therapies in psychotic patients.Psychopharmacology (Berl). 1980;69(1):35-7. doi: 10.1007/BF00426518. Psychopharmacology (Berl). 1980. PMID: 6771823
-
Kinetics of oral fluphenazine disposition in humans by GC-MS.Eur J Clin Pharmacol. 1983;25(5):709-11. doi: 10.1007/BF00542363. Eur J Clin Pharmacol. 1983. PMID: 6662169
-
Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment.Psychopharmacology (Berl). 1983;81(4):359-62. doi: 10.1007/BF00427579. Psychopharmacology (Berl). 1983. PMID: 6140703
-
Radioimmunoassay for trifluoperazine in human plasma.Br J Clin Pharmacol. 1981 Aug;12(2):189-93. doi: 10.1111/j.1365-2125.1981.tb01199.x. Br J Clin Pharmacol. 1981. PMID: 7306433 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources